| Serial Number | 85390442 |
| Word Mark | CBL |
| Filing Date | Friday, August 5, 2011 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, December 20, 2019 |
| Registration Number | 4333516 |
| Registration Date | Tuesday, May 14, 2013 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 26, 2013 |
| Goods and Services | Active chemical ingredients and excipients for use in the manufacture of pharmaceuticals consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for pharmaceutical actives |
| Goods and Services | Analgesic and muscle relaxant pharmaceutical preparations; Anti-diabetic pharmaceuticals; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals; Cellulose esters for pharmaceutical purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for tablets that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for skin care; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceuticals, namely, lipid lowering agents |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, December 20, 2019 |
| Primary Code | 001 |
| First Use Anywhere Date | Sunday, March 20, 2011 |
| First Use In Commerce Date | Sunday, March 20, 2011 |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, December 20, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | Sunday, March 20, 2011 |
| First Use In Commerce Date | Sunday, March 20, 2011 |
| Party Name | Chantilly bioPharma |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Chantilly, VA 20151 |
| Party Name | Chantilly bioPharma |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Chantilly, VA 20151 |
| Party Name | Chantilly bioPharma |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Chantilly, VA 20151 |
| Event Date | Event Description |
| Friday, December 20, 2019 | CANCELLED SEC. 8 (6-YR) |
| Monday, May 14, 2018 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, May 14, 2013 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, February 26, 2013 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 26, 2013 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 6, 2013 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, January 23, 2013 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, January 23, 2013 | ASSIGNED TO LIE |
| Tuesday, January 8, 2013 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, December 11, 2012 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, December 11, 2012 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, December 11, 2012 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, August 13, 2012 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, August 13, 2012 | NON-FINAL ACTION E-MAILED |
| Monday, August 13, 2012 | NON-FINAL ACTION WRITTEN |
| Tuesday, July 3, 2012 | ASSIGNED TO EXAMINER |
| Wednesday, June 6, 2012 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, June 5, 2012 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, June 5, 2012 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, December 12, 2011 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, December 12, 2011 | NON-FINAL ACTION E-MAILED |
| Monday, December 12, 2011 | NON-FINAL ACTION WRITTEN |
| Wednesday, November 30, 2011 | ASSIGNED TO EXAMINER |
| Thursday, August 11, 2011 | NOTICE OF PSEUDO MARK MAILED |
| Wednesday, August 10, 2011 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Tuesday, August 9, 2011 | NEW APPLICATION ENTERED IN TRAM |